54 Publikationen

Alle markieren

  • [54]
    2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2985913 OA
    Rudwaleit M, Morup M, Humphries B, et al. Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis. RMD Open. 2023;9(4): e003468.
    PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
     
  • [53]
    2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984077
    Löffler C, Rudwaleit M, Lakomek H-J, Stammann C, Hellmich B. Patient-reported-Outcomes bei Vaskulitispatienten in Deutschland – Daten aus dem KOBRA-Qualitätsprojekt. Zeitschrift für Rheumatologie. 2023.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [52]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987167
    Rudwaleit M, Brown M, Van Gaalen FA, et al. LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: POOLED RESULTS FROM PHASE 2B/3 TRIALS. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):614-615.
    PUB | DOI | WoS
     
  • [51]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987166
    Rudwaleit M, Van den Bosch F, Marzo-Ortega H, et al. AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT BETWEEN OBJECTIVE INFLAMMATORY RESPONSE AND CLINICAL RESPONSE FOLLOWING CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):624-625.
    PUB | DOI | WoS
     
  • [50]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987165
    Baraliakos X, Machado P, Bauer L, et al. COMPARISON OF ESTABLISHED AND NEW, PRELIMINARY PROPOSED ASAS CUT-OFFS FOR INFLAMMATORY MRI LESIONS IN THE SACROILIAC JOINTS OF AXIAL SPONDYLOARTHRITIS PATIENTS AND IMPLICATIONS FOR RECRUITMENT IN CLINICAL STUDIES. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):621-622.
    PUB | DOI | WoS
     
  • [49]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987161
    Torgutalp M, Peng X, Proft F, et al. FACTORS ASSOCIATED WITH ACHIEVING REMISSION IN PATIENTS WITH EARLY PERIPHERAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT (GESPIC). Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):37-38.
    PUB | DOI | WoS
     
  • [48]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987156
    Schmidt JF, Kiltz U, Stammann C, et al. QUALITY STANDARDS FOR PATIENTS WITH AXSPA - STATUS QUO OF DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF AXSPA PATIENTS IN GERMANY. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):1713.
    PUB | DOI | WoS
     
  • [47]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2980346
    Röchter M, Thiesbrummel S, Marchi H, Fuchs C, Rudwaleit M. Changes in diagnosing giant cell arteritis of the temporal artery over a 7.7 year period. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):1579.
    PUB | DOI | WoS
     
  • [46]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987168
    Baraliakos X, Ramiro S, Magrey M, et al. ACHIEVEMENT OF LOW DISEASE ACTIVITY OVER 52 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS ON BIMEKIZUMAB TREATMENT: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):875-876.
    PUB | DOI | WoS
     
  • [45]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987172
    Albrecht K, Thiele K, Aringer M, et al. IMPLEMENTATION OF QUALITY STANDARDS FOR HEALTH CARE OF PATIENTS WITH RHEUMATOID ARTHRITIS: FIRST RESULTS FROM THE NATIONAL DATABASE OF THE GERMAN COLLABORATIVE ARTHRITIS CENTRES. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):868-869.
    PUB | DOI | WoS
     
  • [44]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987170
    Magrey M, Deodhar A, Mease PJ, et al. ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):1721.
    PUB | DOI | WoS
     
  • [43]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987174
    Navarro-Compán V, Benavent D, Capelusnik D, et al. ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):35-36.
    PUB | DOI | WoS
     
  • [42]
    2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2986690
    van Gaalen FA, Rudwaleit M. Challenges in the diagnosis of axial spondyloarthritis. Best Practice & Research Clinical Rheumatology. 2023;37(3): 101871.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [41]
    2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2985592
    Braun J, Rudwaleit M, Sieper J. Zur Rolle von HLA-B27 in der Pathogenese und Diagnostik der axialen Spondyloarthritis. 50 Jahre nach Entdeckung der starken genetischen Assoziation. Zeitschrift fur Rheumatologie. 2023.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [40]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2983818
    Baraliakos X, Ramiro S, Magrey M, et al. Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2. In: Abstracts of the Annual meeting of theSwiss Society of Rheumatology. Swiss Medical Weekly. Vol 153. Basel: EMH Schweizerischer Ärzteverlag; 2023: 23S.
    PUB | DOI | WoS
     
  • [39]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2984578
    Baraliakos X, Ramiro S, Magrey M, et al. Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the Phase 3 studies BE MOBILE 1 and BE MOBILE 2. In: Abstract Supplement - 39th Scandinavian Congress of Rheumatology. Scandinavian Journal of Rheumatology . Vol 52. Abingdon: Taylor & Francis ; 2023: 73-74.
    PUB | DOI | WoS
     
  • [38]
    2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2982993
    Rudwaleit M, Machado PM, Taieb V, de Peyrecave N, Hoepken B, Gensler LS. Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease . 2023;15.
    PUB | DOI | PubMed | Europe PMC
     
  • [37]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982790
    Zochling J, Robinson PC, Maksymowych WP, et al. Long-term clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis stratified by baseline MRI and c-reactive protein status. Internal Medicine Journal. 2023;53(Suppl. 1):25.
    PUB | DOI | WoS
     
  • [36]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982783
    Rudwaleit M, Morup M, Humphries B, et al. Systematic Literature Review and Meta-Analysis of Work Productivity in Patients with Axial Spondyloarthritis Treated with Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs. Value in Health. 2023;26(6 Suppl.):S397.
    PUB | DOI | WoS
     
  • [35]
    2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982796
    Bird P, Mease PJ, Deodhar A, et al. Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. Internal Medicine Journal. 2023;53(S2):24-25.
    PUB | WoS
     
  • [34]
    2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968910
    Braun J, Rudwaleit M, Sieper J, Specker C. Nachruf der Deutschen Gesellschaft für Rheumatologie (DGRh) auf den Träger der Kussmaul-Medaille der DGRh Prof. Dr. Ernst Feldtkeller. Zeitschrift für Rheumatologie. 2023.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [33]
    2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968373
    Röchter M-H, Rudwaleit M. Phänomen der letzten Wiese. Zeitschrift fur Rheumatologie. 2023.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [32]
    2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968388 OA
    van der Heijde D, Deodhar A, Baraliakos X, et al. Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the Rheumatic Diseases. 2023.
    PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
     
  • [31]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2969537
    Magrey M, Deodhar A, Mease PJ, et al. Association of Clinical Response Criteria and Disease Activity Levels With Physical Function and HRQoL in Patients With Active Axial Spondyloarthritis: 16-Week Results From Two Phase 3 Randomised, Placebo-Controlled Studies. In: ISPOR Europe 2022 Abstracts. Value in Health. Vol 25. New York: Elsevier ; 2022: S427-S428.
    PUB | DOI | WoS
     
  • [30]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968210
    Torgutalp M, Rios-Rodriguez V, Dilbaryan A, et al. Treatment with Non-steroidal Anti-inflammatory Drugs Is Associated with Retardation of Radiographic Spinal Progression in Patients with Axial Spondyloarthritis: 10-year Results from the GErman SPondyloarthritis Inception Cohort. In: American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 2946-2948.
    PUB | DOI | WoS
     
  • [29]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968211
    Baraliakos X, Machado P, Bauer L, et al. Comparison of Established and New, Preliminarily Proposed ASAS Cut-Offs for Inflammatory MRI Lesions in the Sacroiliac Joints of Axial Spondyloarthritis Patients and Implications for Recruitment in Clinical Studies. In: American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 1997-2000.
    PUB | DOI | WoS
     
  • [28]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968213
    Brandt-Juergens J, Rudwaleit M, Behrens F, et al. Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis. In: American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 2074-2076.
    PUB | DOI | WoS
     
  • [27]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968219
    Deodhar A, van der Heijde D, Gensler L, et al. Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients with Active Non-Radiographic Axial Spondyloarthritis: 24-Week Efficacy & Safety from a Phase 3, Multicenter, Randomized, Placebo Controlled Study. In: American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 1101-1105.
    PUB | DOI | WoS
     
  • [26]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968220
    Diekhoff T, Eshed I, Giraudo C, et al. ASAS Recommendations for Requesting and Reporting Imaging in Patients with Suspected Axial Spondyloarthritis. In: American College of Reumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 788-790.
    PUB | DOI | WoS
     
  • [25]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968222
    Ramiro S, Nikiphorou E, Sepriano A, et al. ASAS-EULAR Recommendations for the Management of Axial Spondyloarthritis: 2022 Update. In: American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022 ,November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 1094-1097.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [24]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968218
    Mease PJ, Deodhar A, Dougados M, et al. Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. In: American College of Rheumatolgy, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 810-813.
    PUB | DOI | WoS
     
  • [23]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968217
    Maksymowych WP, Ostergaard M, Baraliakos X, et al. MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis. In: American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 4490-4492.
    PUB | DOI | WoS
     
  • [22]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968216
    Magrey M, Deodhar A, Mease PJ, et al. Achieving Increasingly Stringent Clinical Response Criteria & Lower Levels of Disease Activity Is Associated with Greater Improvements in Physical Function & HRQoL in Patients with Active Axial Spondyloarthritis: 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies. In: American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 814-816.
    PUB | DOI | WoS
     
  • [21]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968215
    Rudwaleit M, Van den Bosch F, Marzo-Ortega H, et al. An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis. In: American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 1097-1100.
    PUB | DOI | WoS
     
  • [20]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968214
    Robinson PC, Maksymowych WP, Gensler L, et al. Long-Term Clinical Outcomes of Certolizumab Pegol Treatment in Patients with Active Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status. In: American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 808-810.
    PUB | DOI | WoS
     
  • [19]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966738
    Navarro-Compan V, Rudwaleit M, De Peyrecave N, et al. MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION. Annals of the Rheumatic Diseases. 2022;81(Suppl. 1):771-772.
    PUB | DOI | WoS
     
  • [18]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966741
    Torgutalp M, Rodriguez VR, Dilbaryan A, et al. TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IS ASSOCIATED WITH RETARDATION OF RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT. In: Annals of the Rheumatic Diseases. Vol 81. London: Bmj Publishing Group; 2022: 14-15.
    PUB | DOI | WoS
     
  • [17]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966746
    Robinson P, Maksymowych WP, Gensler LS, et al. LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS. In: Annals of the Rheumatic Diseases. Vol 81. London: Bmj Publishing Group; 2022: 774-775.
    PUB | DOI | WoS
     
  • [16]
    2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966748
    Deodhar A, Van der Heijde D, Gensler LS, et al. BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY. In: Annals of the Rheumatic Diseases. Vol 81. London: Bmj Publishing Group; 2022: 772-773.
    PUB | DOI | WoS
     
  • [15]
    2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2965259
    Torgutalp M, Rodriguez VR, Proft F, et al. Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort. Arthritis & Rheumatology . 2022.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [14]
    2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2963951 OA
    Torgutalp M, Rios Rodriguez V, Dilbaryan A, et al. Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis. Annals of the rheumatic diseases. 2022;81(9):1252-1259.
    PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
     
  • [13]
    2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2964357
    Robinson PC, Maksymowych WP, Gensler LS, et al. Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study. ACR Open Rheumatology. 2022.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [12]
    2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2963700
    Baraliakos X, Ostergaard M, Lambert RG, et al. MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group. Annals of the Rheumatic Diseases. 2022.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [11]
    2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2962214
    van der Heijde D, Gensler LS, Maksymowych WP, et al. Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. RMD Open. 2022;8(1): e002138.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [10]
    2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961894
    Baraliakos X, Rodriguez VR, Torgutalp M, et al. Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time? In: American College of Rheumatology, ed. Abstract Supplement ACR Convergence 2021 . Arthritis & Rheumatology . Vol 73. Hoboken: Wiley; 2021: 319-321.
    PUB | DOI | WoS
     
  • [9]
    2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961900
    Maksymowych W, Lambert R, Baraliakos X, et al. Data-driven Definitions Based on Inflammatory Lesions for a Positive MRI of the Spine Consistent with Axial Spondyloarthritis. In: American College of Rheumatology, ed. Abstract Supplement ACR Convergence 2021. Arthritis & Rheumatology. Vol 73. Hoboken: Wiley; 2021: 1878-1880.
    PUB | DOI | WoS
     
  • [8]
    2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961899
    Maksymowych W, Weber U, Baraliakos X, et al. Scoring MRI Structural Lesions in Sacroiliac Joints of Patients with Axial Spondyloarthritis: How Many Slices Are Optimal? In: American College of Rheumatology, ed. Abstract Supplement ACR Convergence 2021. Arthritis & Rheumatology. Vol 73. Hoboken: Wiley; 2021: 1876-1878.
    PUB | DOI | WoS
     
  • [7]
    2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961897
    van der Heijde D, Gensler L, Maksymowych W, et al. Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Active Non-Radiographic Axial Spondyloarthritis: 3-Year Results from a Phase 3 Multicenter Study. In: American College of Rheumatology, ed. Abstract Supplement ACR Convergence 2021. Arthritis & Rheumatology. Vol 73. Hoboken: Wiley; 2021: 1896-1899.
    PUB | DOI | WoS
     
  • [6]
    2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961896
    Magrey M, Ramiro SA, Pinheiro MM, et al. Predictors of 1-Year Treatment Response Among Upadacitinib-Treated Patients with Ankylosing Spondylitis: A Post Hoc Analysis. In: American College of Rheumatology, ed. Abstract Supplement ACR Convergence 2021 . Arthritis & Rheumatology . Vol 73. Hoboken: Wiley; 2021: 1931-1933.
    PUB | DOI | WoS
     
  • [5]
    2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961895
    Rudwaleit M, Machado P, Gensler L, et al. Achievement of Stringent Thresholds of Disease Control Is Associated with Reduced Burden on Work and Household Productivity in Patients with Axial Spondyloarthritis. In: American College of Rheumatology, ed. Abstract Supplement ACR Convergence 2021 . Arthritis & Rheumatology . Vol 73. Hoboken: Wiley; 2021: 734-738.
    PUB | DOI | WoS
     
  • [4]
    2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961892
    Torgutalp M, Rodriguez VR, Verba M, et al. Tumor Necrosis Factor Inhibitors Show a Delayed Effect on Radiographic Sacroiliitis Progression in Patients with Early Axial Spondyloarthritis: 10-Year Results from the German Spondyloarthritis Inception Cohort. In: American College of Rheumatology, ed. Abstract Supplement ACR Convergence 2021 . Arthritis & Rheumatology . Vol 73. Hoboken: Wiley; 2021: 931-933.
    PUB | DOI | WoS
     
  • [3]
    2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961881
    Kristensen LE, McGonagle D, Rudwaleit M, et al. Association of the improvement of Synovitis and Enthesitis with quality of life/patient reported outcomes in patients with PsA treated with Ixekizumab. In: American College of Rheumatology, ed. Abstract Supplement ACR Convergence 2021 . Arthritis & Rheumatology . Vol 73. Hoboken: Wiley; 2021: 3722-3724.
    PUB | DOI | WoS
     
  • [2]
    2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2959486
    Maksymowych WP, Kumke T, Auteri SE, Hoepken B, Bauer L, Rudwaleit M. Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol. Arthritis Research and Therapy . 2021;23(1): 274.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [1]
    2021 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2958359
    Kiltz U, Buschhorn-Milberger V, Albrecht K, et al. Entwicklung von Qualitätsstandards für die Versorgung von Patient*innen mit rheumatoider Arthritis zur Anwendung in Deutschland. Zeitschrift fur Rheumatologie. 2021.
    PUB | DOI | WoS | PubMed | Europe PMC
     

Suche

Publikationen filtern

Darstellung / Sortierung

Export / Einbettung